Sophora flavescens Alkaloids and Corticosteroid Synergistically Augment IL-10/IL-5 Ratio with Foxp3-Gene-Epigenetic Modification in Asthma PBMCs
It has been demonstrated that ASHMI (antiasthma-simplified herbal medicine intervention) can improve airway function and reduce inflammation in human asthmatic patients with high safety and tolerability. In addition, ASHMI significantly suppresses Th2 cytokine production and increases Th1 cytokine p...
Saved in:
| Published in | Journal of asthma and allergy Vol. 14; pp. 1559 - 1571 |
|---|---|
| Main Authors | , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
New Zealand
Dove Medical Press Limited
01.01.2021
Taylor & Francis Ltd Dove Dove Medical Press |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1178-6965 1178-6965 |
| DOI | 10.2147/JAA.S321616 |
Cover
| Abstract | It has been demonstrated that ASHMI (antiasthma-simplified herbal medicine intervention) can improve airway function and reduce inflammation in human asthmatic patients with high safety and tolerability. In addition, ASHMI significantly suppresses Th2 cytokine production and increases Th1 cytokine production in treating asthma.
Allergic asthma is associated with dysregulation of cytokines. We focused on IL-5 and IL-10 as signature Th2 and Treg cytokines to characterize ASHMI immunomodulatory components.
The effects of ASHMI and individual herbal constituents on IL-5 and IL-10 production by PBMCs from asthmatic subjects were determined ex vivo.
(SF)-F2, containing alkaloid compounds, effects on PBMC IL-10 and IL-5 production in the presence or absence of dexamethasone (Dex), and on DNA methylation levels at the
gene promoter were determined.
The ratio of anti-CD3/CD28 stimulated IL-10/IL-5 production by PBMCs from asthmatic subjects was significantly reduced compared to healthy subjects. In PBMCs from asthmatic subjects, ASHMI significantly reduced IL-5 production and increased IL-10 secretion in a dose-dependent manner (p < 0.05-0.01). SF-F2 was most effective in increasing IL-10, whereas SF-F4 (flavonoid compounds) was most effective in suppressing IL-5 production. Dex-treated PBMCs from asthma subjects showed a trend of increasing ratio of IL-10/IL-5 while demonstrating reduced levels in both IL-5 and IL-10 (p < 0.05). Co-culture with Dex and SF-F2 significantly prevented Dex suppression of IL-10, while retained Dex-suppression of IL-5 production, and increased IL-10/IL-5 ratio by Dex. Co-culture with SF-F2 and Dex significantly reduced DNA methylation levels at the
gene promoter at CpG
.
The SF alkaloid-rich fraction may be responsible for ASHMI induction of IL-10 production by PBMCs and plays a synergistic effect with Dex for augmenting IL-10/IL-5 ratio. |
|---|---|
| AbstractList | It has been demonstrated that ASHMI (antiasthma-simplified herbal medicine intervention) can improve airway function and reduce inflammation in human asthmatic patients with high safety and tolerability. In addition, ASHMI significantly suppresses Th2 cytokine production and increases Th1 cytokine production in treating asthma.BACKGROUNDIt has been demonstrated that ASHMI (antiasthma-simplified herbal medicine intervention) can improve airway function and reduce inflammation in human asthmatic patients with high safety and tolerability. In addition, ASHMI significantly suppresses Th2 cytokine production and increases Th1 cytokine production in treating asthma.Allergic asthma is associated with dysregulation of cytokines. We focused on IL-5 and IL-10 as signature Th2 and Treg cytokines to characterize ASHMI immunomodulatory components.OBJECTIVEAllergic asthma is associated with dysregulation of cytokines. We focused on IL-5 and IL-10 as signature Th2 and Treg cytokines to characterize ASHMI immunomodulatory components.The effects of ASHMI and individual herbal constituents on IL-5 and IL-10 production by PBMCs from asthmatic subjects were determined ex vivo. Sophora flavescens (SF)-F2, containing alkaloid compounds, effects on PBMC IL-10 and IL-5 production in the presence or absence of dexamethasone (Dex), and on DNA methylation levels at the foxp3 gene promoter were determined.METHODSThe effects of ASHMI and individual herbal constituents on IL-5 and IL-10 production by PBMCs from asthmatic subjects were determined ex vivo. Sophora flavescens (SF)-F2, containing alkaloid compounds, effects on PBMC IL-10 and IL-5 production in the presence or absence of dexamethasone (Dex), and on DNA methylation levels at the foxp3 gene promoter were determined.The ratio of anti-CD3/CD28 stimulated IL-10/IL-5 production by PBMCs from asthmatic subjects was significantly reduced compared to healthy subjects. In PBMCs from asthmatic subjects, ASHMI significantly reduced IL-5 production and increased IL-10 secretion in a dose-dependent manner (p < 0.05-0.01). SF-F2 was most effective in increasing IL-10, whereas SF-F4 (flavonoid compounds) was most effective in suppressing IL-5 production. Dex-treated PBMCs from asthma subjects showed a trend of increasing ratio of IL-10/IL-5 while demonstrating reduced levels in both IL-5 and IL-10 (p < 0.05). Co-culture with Dex and SF-F2 significantly prevented Dex suppression of IL-10, while retained Dex-suppression of IL-5 production, and increased IL-10/IL-5 ratio by Dex. Co-culture with SF-F2 and Dex significantly reduced DNA methylation levels at the foxp3 gene promoter at CpG-126.RESULTSThe ratio of anti-CD3/CD28 stimulated IL-10/IL-5 production by PBMCs from asthmatic subjects was significantly reduced compared to healthy subjects. In PBMCs from asthmatic subjects, ASHMI significantly reduced IL-5 production and increased IL-10 secretion in a dose-dependent manner (p < 0.05-0.01). SF-F2 was most effective in increasing IL-10, whereas SF-F4 (flavonoid compounds) was most effective in suppressing IL-5 production. Dex-treated PBMCs from asthma subjects showed a trend of increasing ratio of IL-10/IL-5 while demonstrating reduced levels in both IL-5 and IL-10 (p < 0.05). Co-culture with Dex and SF-F2 significantly prevented Dex suppression of IL-10, while retained Dex-suppression of IL-5 production, and increased IL-10/IL-5 ratio by Dex. Co-culture with SF-F2 and Dex significantly reduced DNA methylation levels at the foxp3 gene promoter at CpG-126.The SF alkaloid-rich fraction may be responsible for ASHMI induction of IL-10 production by PBMCs and plays a synergistic effect with Dex for augmenting IL-10/IL-5 ratio.CONCLUSIONThe SF alkaloid-rich fraction may be responsible for ASHMI induction of IL-10 production by PBMCs and plays a synergistic effect with Dex for augmenting IL-10/IL-5 ratio. It has been demonstrated that ASHMI (antiasthma-simplified herbal medicine intervention) can improve airway function and reduce inflammation in human asthmatic patients with high safety and tolerability. In addition, ASHMI significantly suppresses Th2 cytokine production and increases Th1 cytokine production in treating asthma. Allergic asthma is associated with dysregulation of cytokines. We focused on IL-5 and IL-10 as signature Th2 and Treg cytokines to characterize ASHMI immunomodulatory components. The effects of ASHMI and individual herbal constituents on IL-5 and IL-10 production by PBMCs from asthmatic subjects were determined ex vivo. (SF)-F2, containing alkaloid compounds, effects on PBMC IL-10 and IL-5 production in the presence or absence of dexamethasone (Dex), and on DNA methylation levels at the gene promoter were determined. The ratio of anti-CD3/CD28 stimulated IL-10/IL-5 production by PBMCs from asthmatic subjects was significantly reduced compared to healthy subjects. In PBMCs from asthmatic subjects, ASHMI significantly reduced IL-5 production and increased IL-10 secretion in a dose-dependent manner (p < 0.05-0.01). SF-F2 was most effective in increasing IL-10, whereas SF-F4 (flavonoid compounds) was most effective in suppressing IL-5 production. Dex-treated PBMCs from asthma subjects showed a trend of increasing ratio of IL-10/IL-5 while demonstrating reduced levels in both IL-5 and IL-10 (p < 0.05). Co-culture with Dex and SF-F2 significantly prevented Dex suppression of IL-10, while retained Dex-suppression of IL-5 production, and increased IL-10/IL-5 ratio by Dex. Co-culture with SF-F2 and Dex significantly reduced DNA methylation levels at the gene promoter at CpG . The SF alkaloid-rich fraction may be responsible for ASHMI induction of IL-10 production by PBMCs and plays a synergistic effect with Dex for augmenting IL-10/IL-5 ratio. Background: It has been demonstrated that ASHMI (antiasthma-simplified herbal medicine intervention) can improve airway function and reduce inflammation in human asthmatic patients with high safety and tolerability. In addition, ASHMI significantly suppresses Th2 cytokine production and increases Th1 cytokine production in treating asthma. Objective: Allergic asthma is associated with dysregulation of cytokines. We focused on IL-5 and IL-10 as signature Th2 and Treg cytokines to characterize ASHMI immunomodulatory components. Methods: The effects of ASHMI and individual herbal constituents on IL-5 and IL-10 production by PBMCs from asthmatic subjects were determined ex vivo. Sophora flavescens (SF)-F2, containing alkaloid compounds, effects on PBMC IL-10 and IL-5 production in the presence or absence of dexamethasone (Dex), and on DNA methylation levels at the foxp3 gene promoter were determined. Results: The ratio of anti-CD3/CD28 stimulated IL-10/IL-5 production by PBMCs from asthmatic subjects was significantly reduced compared to healthy subjects. In PBMCs from asthmatic subjects, ASHMI significantly reduced IL-5 production and increased IL-10 secretion in a dose-dependent manner (p < 0.05-0.01). SF-F2 was most effective in increasing IL-10, whereas SF-F4 (flavonoid compounds) was most effective in suppressing IL-5 production. Dex-treated PBMCs from asthma subjects showed a trend of increasing ratio of IL-10/IL-5 while demonstrating reduced levels in both IL-5 and IL-10 (p < 0.05). Co-culture with Dex and SF-F2 significantly prevented Dex suppression of IL-10, while retained Dexsuppression of IL-5 production, and increased IL-10/IL-5 ratio by Dex. Co-culture with SF-F2 and Dex significantly reduced DNA methylation levels at the foxp3 gene promoter at Cp[G.sup.-126]. Conclusion: The SF alkaloid-rich fraction may be responsible for ASHMI induction of IL-10 production by PBMCs and plays a synergistic effect with Dex for augmenting IL-10/IL-5 ratio. Keywords: Sophora flavescens, IL-10/IL-5 ratio, asthma, foxp3 methylation, synergistic effect Ying Song,1,2,* Zhen-Zhen Wang,1,3,* Lixin Wang,4,* Paul Faybusovich,2 Kamal Srivastava,3,5 Changda Liu,1,2 Jody Tversky,6 David Dunkin,7 Paula Busse,8 Xianqing Ren,9 Rachel Miller,8 Mingsan Miao,1 Xiu-Min Li3,10 1Academy of Chinese Medicine, Henan University of Chinese Medicine, Zhengzhou, People’s Republic of China; 2Department of Pediatrics, Division of Allergy and Immunology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; 3Department of Pathology, Microbiology and Immunology, New York Medical College, Valhalla, NY, USA; 4Integrated TCM & Western Medicine Department, Shanghai Pulmonary Hospital Affiliated to Tongji University, Shanghai, People’s Republic of China; 5General Nutraceutical Technology LLC, Elmsford, NY, USA; 6The Department of Medicine, Division of Allergy and Clinical Immunology, Johns Hopkins Asthma and Allergy Center, Baltimore, Maryland, USA; 7Department of Pediatrics, Division of Gastroenterology and Nutrition, Icahn School of Medicine at Mount Sinai, New York, NY, USA; 8Division of Clinical Immunology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA; 9The First Affiliated Hospital of Henan University of TCM, Zhengzhou, People’s Republic of China; 10Department of Otolaryngology, New York Medical College, Ardsley, NY, USA*These authors contributed equally to this workCorrespondence: Xiu-Min LiProfessor of Pathology, Microbiology and Immunology, New York Medical College, Valhalla, NY Email XiuMin_Li@NYMC.eduBackground: It has been demonstrated that ASHMI (antiasthma-simplified herbal medicine intervention) can improve airway function and reduce inflammation in human asthmatic patients with high safety and tolerability. In addition, ASHMI significantly suppresses Th2 cytokine production and increases Th1 cytokine production in treating asthma.Objective: Allergic asthma is associated with dysregulation of cytokines. We focused on IL-5 and IL-10 as signature Th2 and Treg cytokines to characterize ASHMI immunomodulatory components.Methods: The effects of ASHMI and individual herbal constituents on IL-5 and IL-10 production by PBMCs from asthmatic subjects were determined ex vivo. Sophora flavescens (SF)-F2, containing alkaloid compounds, effects on PBMC IL-10 and IL-5 production in the presence or absence of dexamethasone (Dex), and on DNA methylation levels at the foxp3 gene promoter were determined.Results: The ratio of anti-CD3/CD28 stimulated IL-10/IL-5 production by PBMCs from asthmatic subjects was significantly reduced compared to healthy subjects. In PBMCs from asthmatic subjects, ASHMI significantly reduced IL-5 production and increased IL-10 secretion in a dose-dependent manner (p < 0.05– 0.01). SF-F2 was most effective in increasing IL-10, whereas SF-F4 (flavonoid compounds) was most effective in suppressing IL-5 production. Dex-treated PBMCs from asthma subjects showed a trend of increasing ratio of IL-10/IL-5 while demonstrating reduced levels in both IL-5 and IL-10 (p < 0.05). Co-culture with Dex and SF-F2 significantly prevented Dex suppression of IL-10, while retained Dex-suppression of IL-5 production, and increased IL-10/IL-5 ratio by Dex. Co-culture with SF-F2 and Dex significantly reduced DNA methylation levels at the foxp3 gene promoter at CpG− 126.Conclusion: The SF alkaloid-rich fraction may be responsible for ASHMI induction of IL-10 production by PBMCs and plays a synergistic effect with Dex for augmenting IL-10/IL-5 ratio.Keywords: Sophora flavescens, IL-10/IL-5 ratio, asthma, foxp3 methylation, synergistic effect Background: It has been demonstrated that ASHMI (antiasthma-simplified herbal medicine intervention) can improve airway function and reduce inflammation in human asthmatic patients with high safety and tolerability. In addition, ASHMI significantly suppresses Th2 cytokine production and increases Th1 cytokine production in treating asthma. Objective: Allergic asthma is associated with dysregulation of cytokines. We focused on IL-5 and IL-10 as signature Th2 and Treg cytokines to characterize ASHMI immunomodulatory components. Methods: The effects of ASHMI and individual herbal constituents on IL-5 and IL-10 production by PBMCs from asthmatic subjects were determined ex vivo. Sophora flavescens (SF)-F2, containing alkaloid compounds, effects on PBMC IL-10 and IL-5 production in the presence or absence of dexamethasone (Dex), and on DNA methylation levels at the foxp3 gene promoter were determined. Results: The ratio of anti-CD3/CD28 stimulated IL-10/IL-5 production by PBMCs from asthmatic subjects was significantly reduced compared to healthy subjects. In PBMCs from asthmatic subjects, ASHMI significantly reduced IL-5 production and increased IL-10 secretion in a dose-dependent manner (p < 0.05– 0.01). SF-F2 was most effective in increasing IL-10, whereas SF-F4 (flavonoid compounds) was most effective in suppressing IL-5 production. Dex-treated PBMCs from asthma subjects showed a trend of increasing ratio of IL-10/IL-5 while demonstrating reduced levels in both IL-5 and IL-10 (p < 0.05). Co-culture with Dex and SF-F2 significantly prevented Dex suppression of IL-10, while retained Dex-suppression of IL-5 production, and increased IL-10/IL-5 ratio by Dex. Co-culture with SF-F2 and Dex significantly reduced DNA methylation levels at the foxp3 gene promoter at CpG− 126. Conclusion: The SF alkaloid-rich fraction may be responsible for ASHMI induction of IL-10 production by PBMCs and plays a synergistic effect with Dex for augmenting IL-10/IL-5 ratio. |
| Audience | Academic |
| Author | Wang, Zhen-Zhen Liu, Changda Ren, Xianqing Dunkin, David Wang, Lixin Faybusovich, Paul Song, Ying Busse, Paula Miao, Mingsan Tversky, Jody Srivastava, Kamal Miller, Rachel Li, Xiu-Min |
| Author_xml | – sequence: 1 givenname: Ying surname: Song fullname: Song, Ying – sequence: 2 givenname: Zhen-Zhen surname: Wang fullname: Wang, Zhen-Zhen – sequence: 3 givenname: Lixin orcidid: 0000-0003-4748-3225 surname: Wang fullname: Wang, Lixin – sequence: 4 givenname: Paul surname: Faybusovich fullname: Faybusovich, Paul – sequence: 5 givenname: Kamal surname: Srivastava fullname: Srivastava, Kamal – sequence: 6 givenname: Changda surname: Liu fullname: Liu, Changda – sequence: 7 givenname: Jody surname: Tversky fullname: Tversky, Jody – sequence: 8 givenname: David surname: Dunkin fullname: Dunkin, David – sequence: 9 givenname: Paula surname: Busse fullname: Busse, Paula – sequence: 10 givenname: Xianqing orcidid: 0000-0002-8390-259X surname: Ren fullname: Ren, Xianqing – sequence: 11 givenname: Rachel surname: Miller fullname: Miller, Rachel – sequence: 12 givenname: Mingsan surname: Miao fullname: Miao, Mingsan – sequence: 13 givenname: Xiu-Min surname: Li fullname: Li, Xiu-Min |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34992384$$D View this record in MEDLINE/PubMed |
| BookMark | eNptk1Fv0zAQxyM0xMbYE-_IEhJCgmyxnTjxC1KotjHUCUTh2brYTuvi2iVONvot-Mi466jasUSKo8vv_jn_7_w8OXDe6SR5ibNTgvPy7HNdn04owQyzJ8kRxmWVMs6Kg533w-QkhHkWL8oZo-xZckhzzgmt8qPkz8QvZ74D1Fq40UFqF1Btf4L1RgUETqGR73ojfeh1F2NosnK6m5oQY2DtCtXDdKFdj67GKc7O4rNA36A3Ht2afoYu_O8lTS-10-n50kzjGvPQtVemjfkRc8g4VId-tgD09eP1KLxInrZggz65X4-THxfn30ef0vGXy6tRPU5lUdI-xUBxUbJSt6rlBQOZNVwxrAiuioaVhEHLlCq1rLKcSaAtoRltQHGoWCM1pcfJ1UZXeZiLZWcW0K2EByPuAr6bClhv3GrBG6JL0K0mXOVSEt7qkmhFc6lynjcqar3faA1uCavb6MtWEGdi3ScxBxBh06eIf9jgy6FZaBU97zuwezXsf3FmJqb-RlQlxlW-rv3tvUDnfw069GJhYuusBaf9EARhuCI0z-7Q1w_QuR86F51dU5yXOcE71BTifo1rffyvXIuKmlW8JEVR8EidPkLFW-lFnBCnWxPjewlvdhJmGmw_C94O676HffDVriNbK_7NaQTebQDZ-RA63f5ncDwIYrI1GD-gpenvpi0WbOyjOX8BlmUIvA |
| CitedBy_id | crossref_primary_10_1016_j_cellsig_2023_110691 crossref_primary_10_1186_s13148_023_01481_1 |
| Cites_doi | 10.1038/nri2870 10.1016/j.phytochem.2013.07.023 10.1186/s40733-015-0012-4 10.1016/j.jaci.2010.06.025 10.1016/j.jep.2015.06.010 10.1002/eji.200322919 10.1034/j.1398-9995.2000.00120.x 10.1016/j.jaci.2005.05.029 10.1142/S0192415X1000783X 10.1164/ajrccm.161.5.9903102 10.1038/s41577-018-0006-6 10.1016/j.anai.2014.01.021 10.1016/S0891-5520(05)70154-9 10.4236/pp.2015.62010 10.1111/j.1399-3038.2006.00406.x 10.4049/jimmunol.175.11.7380 10.1016/0306-3623(91)90452-C 10.11613/BM.2015.004 10.1111/cea.12988 10.1046/j.1365-2222.1999.00584.x 10.1371/journal.pone.0001612 10.1089/acm.2008.0543 10.1186/s40413-015-0063-2 10.4049/jimmunol.1001437 10.1002/ptr.5767 10.1002/ptr.1843 10.1002/14651858.CD010834.pub3 10.1038/nri2262 10.1016/j.smim.2011.06.005 10.1038/nri1934 10.3389/fimmu.2013.00169 10.5415/apallergy.2015.5.4.210 10.1186/s13148-017-0364-0 10.1080/09629350120054518 10.1111/j.1365-2222.2008.03059.x 10.1371/journal.pone.0055307 10.1111/j.1399-3038.2005.00230.x 10.1016/j.immuni.2009.08.007 10.1016/j.fitote.2020.104556 10.1016/j.intimp.2015.05.018 10.1111/j.1365-2222.2010.03545.x 10.3109/02770903.2014.938353 10.1016/j.ejphar.2005.12.052 10.1155/2012/720976 10.1021/acs.jnatprod.8b00576 10.1371/journal.pone.0048796 10.1067/mai.2002.127512 10.3389/fimmu.2018.00455 10.1097/01.all.0000162309.97480.45 10.1016/S0140-6736(00)03496-6 10.1164/rccm.200304-499OC 10.1111/j.1600-065X.2011.01034.x 10.3389/fimmu.2016.00620 10.1378/chest.117.2.542 10.1067/mai.2000.107045 10.1016/j.anai.2011.02.008 |
| ContentType | Journal Article |
| Copyright | 2021 Song et al. COPYRIGHT 2021 Dove Medical Press Limited 2021. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2021 Song et al. 2021 Song et al. |
| Copyright_xml | – notice: 2021 Song et al. – notice: COPYRIGHT 2021 Dove Medical Press Limited – notice: 2021. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2021 Song et al. 2021 Song et al. |
| DBID | AAYXX CITATION NPM 3V. 7RV 7XB 8C1 8FE 8FH 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH HCIFZ KB0 LK8 M2O M7P MBDVC NAPCQ PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI Q9U 7X8 5PM ADTOC UNPAY DOA |
| DOI | 10.2147/JAA.S321616 |
| DatabaseName | CrossRef PubMed ProQuest Central (Corporate) ProQuest Central Nursing & Allied Health database (via ProQuest) ProQuest Central (purchase pre-March 2016) Public Health Database ProQuest SciTech Collection ProQuest Natural Science Journals Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Research Library Prep SciTech Premium Collection Nursing & Allied Health Database (Alumni Edition) Biological Sciences Research Library Biological science database Research Library (Corporate) Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic Publicly Available Content Database (Proquest) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) Unpaywall for CDI: Periodical Content Unpaywall DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef PubMed Publicly Available Content Database Research Library Prep ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Research Library ProQuest Central (New) ProQuest Public Health ProQuest Biological Science Collection ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic PubMed Publicly Available Content Database |
| Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository – sequence: 4 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| DocumentTitleAlternate | Song et al |
| EISSN | 1178-6965 |
| EndPage | 1571 |
| ExternalDocumentID | oai_doaj_org_article_9b2e7aefe29d4cc29fe72ed34cd494bd 10.2147/jaa.s321616 PMC8711843 A689725559 34992384 10_2147_JAA_S321616 |
| Genre | Journal Article |
| GeographicLocations | China |
| GeographicLocations_xml | – name: China |
| GrantInformation_xml | – fundername: ; |
| GroupedDBID | --- 0YH 29J 2WC 5VS 7RV 8C1 8FE 8FH 8FI 8FJ 8G5 AAYXX ABUWG ACGFO ADBBV ADRAZ AFKRA ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BKEYQ BPHCQ BVXVI CCPQU CITATION DIK DWQXO E3Z EBD EBS EJD FYUFA GNUQQ GROUPED_DOAJ GUQSH GX1 HCIFZ HYE IAO IHR IHW IPNFZ ITC KQ8 LK8 M2O M48 M7P M~E NAPCQ O5R O5S OK1 P2P P6G PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQGLB PQQKQ PROAC PUEGO RIG RNS RPM TDBHL TR2 UKHRP VDV ALIPV NPM AQTUD 3V. 7XB 8FK MBDVC PKEHL PQEST PQUKI Q9U 7X8 5PM ADTOC UNPAY |
| ID | FETCH-LOGICAL-c573t-1a315767efdf956ac0b9d61d2185b6726af6dd7ec8046ca3f2303bad9a86bce33 |
| IEDL.DBID | UNPAY |
| ISSN | 1178-6965 |
| IngestDate | Tue Oct 14 18:57:44 EDT 2025 Sun Oct 26 03:30:17 EDT 2025 Tue Sep 30 16:23:11 EDT 2025 Thu Sep 04 15:54:51 EDT 2025 Fri Jul 25 11:44:40 EDT 2025 Mon Oct 20 21:46:46 EDT 2025 Mon Oct 20 16:47:27 EDT 2025 Thu May 22 21:22:21 EDT 2025 Thu Apr 03 06:52:50 EDT 2025 Wed Oct 01 04:12:18 EDT 2025 Thu Apr 24 22:59:05 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | asthma IL-10/IL-5 ratio Sophora flavescens foxp3 methylation synergistic effect |
| Language | English |
| License | http://creativecommons.org/licenses/by-nc/3.0 2021 Song et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). cc-by-nc |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c573t-1a315767efdf956ac0b9d61d2185b6726af6dd7ec8046ca3f2303bad9a86bce33 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 These authors contributed equally to this work |
| ORCID | 0000-0002-8390-259X 0000-0003-4748-3225 |
| OpenAccessLink | https://proxy.k.utb.cz/login?url=https://www.dovepress.com/getfile.php?fileID=77043 |
| PMID | 34992384 |
| PQID | 2619974213 |
| PQPubID | 3933137 |
| PageCount | 13 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_9b2e7aefe29d4cc29fe72ed34cd494bd unpaywall_primary_10_2147_jaa_s321616 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8711843 proquest_miscellaneous_2618234043 proquest_journals_2619974213 gale_infotracmisc_A689725559 gale_infotracacademiconefile_A689725559 gale_healthsolutions_A689725559 pubmed_primary_34992384 crossref_primary_10_2147_JAA_S321616 crossref_citationtrail_10_2147_JAA_S321616 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2021-01-01 |
| PublicationDateYYYYMMDD | 2021-01-01 |
| PublicationDate_xml | – month: 01 year: 2021 text: 2021-01-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | New Zealand |
| PublicationPlace_xml | – name: New Zealand – name: Macclesfield |
| PublicationTitle | Journal of asthma and allergy |
| PublicationTitleAlternate | J Asthma Allergy |
| PublicationYear | 2021 |
| Publisher | Dove Medical Press Limited Taylor & Francis Ltd Dove Dove Medical Press |
| Publisher_xml | – name: Dove Medical Press Limited – name: Taylor & Francis Ltd – name: Dove – name: Dove Medical Press |
| References | Wen (ref27) 2005; 116 Lloyd (ref1) 2010; 10 Povoleri (ref37) 2013; 4 Barnes (ref19) 2006; 533 Yalcin (ref8) 2012; 2012 Oh (ref9) 2002; 110 Trifunović (ref49) 2015; 25 Srivastava (ref26) 2010; 40 Janson (ref42) 2008; 3 Lloyd (ref4) 2009; 31 Whalen (ref14) 2008; 38 Holgate (ref16) 2008; 8 Runyon (ref36) 2012; 7 Bousquet (ref54) 2000; 161 Noma (ref10) 1999; 29 Nakamura (ref5) 2000; 105 Hsu (ref28) 2005; 16 Ngoc (ref2) 2005; 5 Farne (ref56) 2017; 9 Lei (ref41) 2010; 185 Akdis (ref13) 2015; 8 Klein (ref18) 2001; 15 Nawijn (ref21) 2013; 8 Raeiszadeh Jahromi (ref50) 2014; 51 Leckie (ref55) 2000; 356 Schülke (ref47) 2018; 9 Stock (ref20) 2005; 175 Guerra (ref6) 2004; 169 Chang (ref30) 2006; 20 North (ref34) 2011; 106 Maruyama (ref38) 2011; 23 Lizasoain (ref43) 1991; 22 Barnes (ref7) 2018; 18 Larché (ref22) 2006; 6 Akdis (ref15) 2000; 55 Cochrane (ref17) 2000; 117 Blanquiceth (ref48) 2016; 7 Nguyen (ref24) 2011; 242 He (ref46) 2015; 172 Kelly-Pieper (ref25) 2009; 15 Tomiita (ref11) 2015; 5 Gallily (ref44) 2015; 6 Lovinsky-Desir (ref40) 2017; 9 Barton (ref53) 2017; 47 Marques (ref35) 2015; 1 Zhou (ref52) 2010; 38 Jutel (ref23) 2003; 33 Yang (ref32) 2013; 95 Liu (ref33) 2017; 31 Chan (ref29) 2006; 17 Chung (ref12) 2001; 10 Zhang (ref51) 2018; 81 Robinson (ref3) 2010; 126 Srivastava (ref39) 2014; 112 Li (ref45) 2020; 143 Liu (ref31) 2015; 27 |
| References_xml | – volume: 10 start-page: 838 year: 2010 ident: ref1 publication-title: Nat Rev Immunol doi: 10.1038/nri2870 – volume: 95 start-page: 259 year: 2013 ident: ref32 publication-title: Phytochemistry doi: 10.1016/j.phytochem.2013.07.023 – volume: 1 start-page: 10 year: 2015 ident: ref35 publication-title: Asthma Res Pract doi: 10.1186/s40733-015-0012-4 – volume: 126 year: 2010 ident: ref3 publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2010.06.025 – volume: 172 start-page: 10 year: 2015 ident: ref46 publication-title: J Ethnopharmacol doi: 10.1016/j.jep.2015.06.010 – volume: 33 start-page: 1205 year: 2003 ident: ref23 publication-title: Eur J Immunol doi: 10.1002/eji.200322919 – volume: 55 start-page: 522 year: 2000 ident: ref15 publication-title: Allergy doi: 10.1034/j.1398-9995.2000.00120.x – volume: 116 start-page: 517 year: 2005 ident: ref27 publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2005.05.029 – volume: 38 start-page: 265 year: 2010 ident: ref52 publication-title: Am J Chin Med doi: 10.1142/S0192415X1000783X – volume: 161 start-page: 1720 year: 2000 ident: ref54 publication-title: Am J Respir Crit Care Med doi: 10.1164/ajrccm.161.5.9903102 – volume: 18 start-page: 454 year: 2018 ident: ref7 publication-title: Nat Rev Immunol doi: 10.1038/s41577-018-0006-6 – volume: 112 year: 2014 ident: ref39 publication-title: Ann Allergy Asthma Immunol doi: 10.1016/j.anai.2014.01.021 – volume: 15 start-page: 423 year: 2001 ident: ref18 publication-title: Infect Dis Clin North Am doi: 10.1016/S0891-5520(05)70154-9 – volume: 6 start-page: 11 year: 2015 ident: ref44 publication-title: Pharmacol Pharmacy doi: 10.4236/pp.2015.62010 – volume: 17 start-page: 316 year: 2006 ident: ref29 publication-title: Pediatr Allergy Immunol doi: 10.1111/j.1399-3038.2006.00406.x – volume: 175 start-page: 7380 year: 2005 ident: ref20 publication-title: J Immunol doi: 10.4049/jimmunol.175.11.7380 – volume: 22 start-page: 297 year: 1991 ident: ref43 publication-title: Gen Pharmacol doi: 10.1016/0306-3623(91)90452-C – volume: 25 start-page: 36 year: 2015 ident: ref49 publication-title: Biochem Med doi: 10.11613/BM.2015.004 – volume: 47 start-page: 1599 year: 2017 ident: ref53 publication-title: Clin Exp Allergy doi: 10.1111/cea.12988 – volume: 29 start-page: 780 year: 1999 ident: ref10 publication-title: Clin Exp Allergy doi: 10.1046/j.1365-2222.1999.00584.x – volume: 3 start-page: e1612 year: 2008 ident: ref42 publication-title: PLoS One doi: 10.1371/journal.pone.0001612 – volume: 15 start-page: 735 year: 2009 ident: ref25 publication-title: J Altern Complement Med doi: 10.1089/acm.2008.0543 – volume: 8 start-page: 17 year: 2015 ident: ref13 publication-title: World Allergy Organ J doi: 10.1186/s40413-015-0063-2 – volume: 185 start-page: 7186 year: 2010 ident: ref41 publication-title: J Immunol doi: 10.4049/jimmunol.1001437 – volume: 31 start-page: 449 year: 2017 ident: ref33 publication-title: Phytother Res doi: 10.1002/ptr.5767 – volume: 20 start-page: 342 year: 2006 ident: ref30 publication-title: Phytother Res doi: 10.1002/ptr.1843 – volume: 9 start-page: CD010834 year: 2017 ident: ref56 publication-title: Cochrane Database Syst Rev doi: 10.1002/14651858.CD010834.pub3 – volume: 8 start-page: 218 year: 2008 ident: ref16 publication-title: Nat Rev Immunol doi: 10.1038/nri2262 – volume: 23 start-page: 418 year: 2011 ident: ref38 publication-title: Semin Immunol doi: 10.1016/j.smim.2011.06.005 – volume: 6 start-page: 761 year: 2006 ident: ref22 publication-title: Nat Rev Immunol doi: 10.1038/nri1934 – volume: 4 start-page: 169 year: 2013 ident: ref37 publication-title: Front Immunol doi: 10.3389/fimmu.2013.00169 – volume: 5 start-page: 210 year: 2015 ident: ref11 publication-title: Asia Pac Allergy doi: 10.5415/apallergy.2015.5.4.210 – volume: 9 start-page: 65 year: 2017 ident: ref40 publication-title: Clin Epigenetics doi: 10.1186/s13148-017-0364-0 – volume: 10 start-page: 51 year: 2001 ident: ref12 publication-title: Mediators Inflamm doi: 10.1080/09629350120054518 – volume: 38 start-page: 1590 year: 2008 ident: ref14 publication-title: Clin Exp Allergy doi: 10.1111/j.1365-2222.2008.03059.x – volume: 8 start-page: e55307 year: 2013 ident: ref21 publication-title: PLoS One doi: 10.1371/journal.pone.0055307 – volume: 16 start-page: 76 year: 2005 ident: ref28 publication-title: Pediatr Allergy Immunol doi: 10.1111/j.1399-3038.2005.00230.x – volume: 31 start-page: 438 year: 2009 ident: ref4 publication-title: Immunity doi: 10.1016/j.immuni.2009.08.007 – volume: 143 start-page: 104556 year: 2020 ident: ref45 publication-title: Fitoterapia doi: 10.1016/j.fitote.2020.104556 – volume: 27 start-page: 224 year: 2015 ident: ref31 publication-title: Int Immunopharmacol doi: 10.1016/j.intimp.2015.05.018 – volume: 40 start-page: 1678 year: 2010 ident: ref26 publication-title: Clin Exp Allergy doi: 10.1111/j.1365-2222.2010.03545.x – volume: 51 start-page: 1004 year: 2014 ident: ref50 publication-title: J Asthma doi: 10.3109/02770903.2014.938353 – volume: 533 start-page: 2 year: 2006 ident: ref19 publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2005.12.052 – volume: 2012 start-page: 720976 year: 2012 ident: ref8 publication-title: Mediators Inflamm doi: 10.1155/2012/720976 – volume: 81 start-page: 2259 year: 2018 ident: ref51 publication-title: J Nat Prod doi: 10.1021/acs.jnatprod.8b00576 – volume: 7 start-page: e48796 year: 2012 ident: ref36 publication-title: PLoS One doi: 10.1371/journal.pone.0048796 – volume: 110 start-page: 460 year: 2002 ident: ref9 publication-title: J Allergy Clin Immunol doi: 10.1067/mai.2002.127512 – volume: 9 start-page: 455 year: 2018 ident: ref47 publication-title: Front Immunol doi: 10.3389/fimmu.2018.00455 – volume: 5 start-page: 161 year: 2005 ident: ref2 publication-title: Curr Opin Allergy Clin Immunol doi: 10.1097/01.all.0000162309.97480.45 – volume: 356 start-page: 2144 year: 2000 ident: ref55 publication-title: Lancet doi: 10.1016/S0140-6736(00)03496-6 – volume: 169 start-page: 70 year: 2004 ident: ref6 publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.200304-499OC – volume: 242 start-page: 258 year: 2011 ident: ref24 publication-title: Immunol Rev doi: 10.1111/j.1600-065X.2011.01034.x – volume: 7 start-page: 620 year: 2016 ident: ref48 publication-title: Front Immunol doi: 10.3389/fimmu.2016.00620 – volume: 117 start-page: 542 year: 2000 ident: ref17 publication-title: Chest doi: 10.1378/chest.117.2.542 – volume: 105 start-page: 1146 year: 2000 ident: ref5 publication-title: J Allergy Clin Immunol doi: 10.1067/mai.2000.107045 – volume: 106 year: 2011 ident: ref34 publication-title: Ann Allergy Asthma Immunol doi: 10.1016/j.anai.2011.02.008 |
| SSID | ssj0000396636 |
| Score | 2.2105532 |
| Snippet | It has been demonstrated that ASHMI (antiasthma-simplified herbal medicine intervention) can improve airway function and reduce inflammation in human asthmatic... Background: It has been demonstrated that ASHMI (antiasthma-simplified herbal medicine intervention) can improve airway function and reduce inflammation in... Ying Song,1,2,* Zhen-Zhen Wang,1,3,* Lixin Wang,4,* Paul Faybusovich,2 Kamal Srivastava,3,5 Changda Liu,1,2 Jody Tversky,6 David Dunkin,7 Paula Busse,8... |
| SourceID | doaj unpaywall pubmedcentral proquest gale pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 1559 |
| SubjectTerms | Alkaloids Allergens Allergies Antiasthmatic agents Asthma CD28 antigen CD3 antigen Corticosteroids CpG islands Cytokines Deoxyribonucleic acid Dexamethasone DNA DNA methylation Drug dosages Epigenetic inheritance Epigenetics Flavonoids foxp3 methylation Foxp3 protein Gene expression Genes Herbal medicine il-10/il-5 ratio Immunomodulation Immunomodulators Immunotherapy Inflammation Interleukin 10 Interleukin 5 Lymphocytes Lymphocytes T Medicine, Botanic Medicine, Herbal Methylation Original Research Peripheral blood mononuclear cells Quality control Reagents Remission (Medicine) Sophora flavescens sophora flavescent Steroids synergistic effect |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwELbQHoAL4k1gASOBkJBCmzhx4mO22tWyoghRVtqb5VdoISTVpgX1X_CTmXHSqmGRuHDpIZ60tWcyM5_j-YaQl0alDuKKDRVLWJikaR4qXWZhot1Yp5FyzuF-x_QDPz1Pzi7Si71WX3gmrKMH7hZuJHTsMuVKFwubGBOL0mWxsywxNhGJtuh9x7nYA1PeBzNI431_wCgCmMQFT7viPGzLMzorirczFkOywwfhyLP2X_XNe8Hpz4OTN9b1Um1-qqrai0ont8mtPp2kRTeNO-Saq--S69P-hfk98mvWLOegZVpW6odnbmppUX1TVbOwLVW1pZMG78VSj0u4RmcbLAb07M3wcxtarL_g_iF99x5c6Qg-U_oJlUlxA5dC7FqyEKmrw-Ml8npiSSSdNhYPIHmd00VNi3Y1_67ox6PppL1Pzk-OP09Ow74JQ2jSjK3CSLEIMEnmSlsCllJmrIXlkYXUINU8i7kqubWZMzkgbaNYCZiGaWWFyrk2jrEH5KBuavcIy8OZig2W4hqMiUJz-AJ8UynAsXDnAvJmqwtpeoZybJRRSUAqqDgJipO94gKws63wsiPm-LvYESp1J4Js2v4C2JjsbUz-y8YC8hxNQnalqTufIAueiwwwWSoC8tpLoFeAv2xUX9wAE0d-rYHk4UASnmYzHN6aney9SSsR5QLuiyMWkBe7YbwTT8jVrll7mTxmyJUUkIedle4mzQDWQmqWBCQb2O9gVYYj9WLuucYBT2NHoIC82ln6leX-qpRsu-V-_D-W-wm5GePJIb_RdUgOVpdr9xRSv5V-5p_y3yX9Vyw priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELdGJwEviG8CA4wEQkLK2sb5fEAorTqNiVbTyqS9WY7trIWQhKYF9b_gT-bOTcLCEC99iC9p4jvfl32_I-S1FJ4Gu6JswVxmu54X2iJJA9tN9CDxhkJrjfmO6cw_PndPLryLPTJramHwWGWjE42iVoXEHHkfPX3wfZ0h-1B-t7FrFO6uNi00RN1aQb03EGM3yL6DyFg9sj-azE7P2qzLgIF7j_uVWKiHLXr6J3F8OGcOOD5-xzQZBP_revqKofr7EOWtTV6K7U-RZVcs1NFdcqd2LWm8k4V7ZE_n98nNab15_oD8mhflAjhO00z8MChOFY2zryIrlqqiIld0XOC9WPaxgmt0vsXCQIPkDH-3pfHmEnOJ9OMnUKt9-PXoGTKWYjKXgh0rmY0w1vakRIxPLI-k00LhYSTDf7rMaVytF98EPR1Nx9VDcn40-Tw-tuuGDLb0Ara2h4INIT4JdKpSiKuEHCSR8ocK3AQv8QPHF6mvVKBlCFG3FCyF-IYlQkUi9BOpGXtEenmR6ydYKs6EI7EsV6J9jBIfHoC7lhEoGV9ri7xreMFljVaOTTMyDlELMo4D43jNOAtkriEudyAd_yYbIVNbEkTWNheK1SWvFyqPEkcHQqfaiZQrpROlOnC0Yq5UbuQmyiIvUST4rky11Q889sMogPjMiyzy1lCghoBXlqIudIAPR6ytDuVBhxJWtuwON2LHa81S8T_rwCKv2mG8E0_L5brYGJrQYYibZJHHOyltP5pBiAtummuRoCO_nVnpjuTLhcEdh9gauwNZ5E0r6dem-4sQvNpN99P_v_4zctvB80EmnXVAeuvVRj8HB2-dvKhX7W_RtFE2 priority: 102 providerName: ProQuest – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELfGkIAXxDeBAUbiQ0LKtsSJUz8glFWbxkQRolTaW-SvbIWQZE0L9L_gT-bOSatl2wMvfYgvaeI7--5n-35HyCstYwt-xfiSRcyP4njgS5UnfqTsrooDaa3F9Y7RZ344iY6O4-MNskoh6DqwuRLaYT2pyazY_nO2_AAD_j0eYw6iZOcoTbfHLITYhb-pz3ysKIU7r115jWvkOngtgWUdRl3o72ZpBoG-qyAYBACkuOBxm7538ZE9h-V4_S_P3ufc18WjlTcXZS2Xv2VRnPNbB3fI7S7gpGlrIXfJhi3vkRujbkv9Pvk7rupTsAOaF_KX43ZqaFr8kEU1NQ2VpaHDCu_FZJAZXKPjJaYLOn5n-LslTRcnuMJIP36CyXYHfmP6FdVNcYmXgnermY_k1v5-jcyfmDRJR5XBI0rOKui0pGkzP_0p6Ze90bB5QCYH-9-Gh35XpsHXccLmfiBZAKglsbnJAW1JvauE4YGB4CFWPAm5zLkxidUDwOJashxQD1PSCDngSlvGHpLNsirtY0wgZzLUmKyr0WsKxeEBuJcpYOrh1nrk3UoXme44zLGURpEBlkHFZaC4rFOcB5a4Eq5b6o6rxfZQqWsR5Nt2F6rZSdYN30yo0CbS5jYUJtI6FLlNQmtYpE0kImU88gJNImuTV9ezRpbygUgAtcXCI2-dBFoyvLKWXfoDfDgycPUkt3qSMN51v3lldtlquGSIgwEZhgHzyMt1M96JZ-hKWy2czCBkyKbkkUetla4_mgHwheAt8kjSs99er_RbyumpYyMHxI01gzzyem3pl7r7u5RZ03b3k_94v6fkVohHh9xK1xbZnM8W9hnEfnP13A3if7bYV_Y priority: 102 providerName: Scholars Portal |
| Title | Sophora flavescens Alkaloids and Corticosteroid Synergistically Augment IL-10/IL-5 Ratio with Foxp3-Gene-Epigenetic Modification in Asthma PBMCs |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/34992384 https://www.proquest.com/docview/2619974213 https://www.proquest.com/docview/2618234043 https://pubmed.ncbi.nlm.nih.gov/PMC8711843 https://www.dovepress.com/getfile.php?fileID=77043 https://doaj.org/article/9b2e7aefe29d4cc29fe72ed34cd494bd |
| UnpaywallVersion | publishedVersion |
| Volume | 14 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1178-6965 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000396636 issn: 1178-6965 databaseCode: KQ8 dateStart: 20080101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAON databaseName: Directory of Open Access Journals customDbUrl: eissn: 1178-6965 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000396636 issn: 1178-6965 databaseCode: DOA dateStart: 20080101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1178-6965 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000396636 issn: 1178-6965 databaseCode: DIK dateStart: 20080101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1178-6965 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000396636 issn: 1178-6965 databaseCode: GX1 dateStart: 20080101 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1178-6965 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000396636 issn: 1178-6965 databaseCode: GX1 dateStart: 0 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1178-6965 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000396636 issn: 1178-6965 databaseCode: M~E dateStart: 20080101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 1178-6965 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000396636 issn: 1178-6965 databaseCode: RPM dateStart: 20080101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 1178-6965 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000396636 issn: 1178-6965 databaseCode: BENPR dateStart: 20080101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Public Health Database customDbUrl: eissn: 1178-6965 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000396636 issn: 1178-6965 databaseCode: 8C1 dateStart: 20080101 isFulltext: true titleUrlDefault: https://search.proquest.com/publichealth providerName: ProQuest – providerCode: PRVFZP databaseName: Scholars Portal Journals: Open Access customDbUrl: eissn: 1178-6965 dateEnd: 20250131 omitProxy: true ssIdentifier: ssj0000396636 issn: 1178-6965 databaseCode: M48 dateStart: 20080901 isFulltext: true titleUrlDefault: http://journals.scholarsportal.info providerName: Scholars Portal – providerCode: PRVAWR databaseName: Taylor and Francis Online customDbUrl: eissn: 1178-6965 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000396636 issn: 1178-6965 databaseCode: 0YH dateStart: 20081201 isFulltext: true titleUrlDefault: https://www.tandfonline.com providerName: Taylor & Francis |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bb9owFLZakLa97H7J1jFP2jRpUiiJEyd5DIiKVQOhMqT2KXJsp7CyBBHoxH7FfvLOSQJq2j1sLxaKTxAOn88t53wm5IMUrga7okzBHGY6ruubIk4804l1J3YtobXGfMdwxAdT5_TcPT8g9q4XBssqVXZdVoGW2SS9RoqigiwCP4AC87yOww5Jk7vgfzdIczoahxflKSq-yQPulo14eATP8Xch2jmzwbHhNdNTMPTf1cM3DNHtIsn7m3Qptj_FYnHDAp08KrsC84K4EAtPrtqbddyWv27ROv7f4h6Th5VDSsMSQU_IgU6fknvD6pX7M_J7ki1ngBOaLMR1wf2U03BxJRbZXOVUpIr2MrwXm0VWcI1OtthOWPA_wyK2NNxcYgaSfvkKyvgYRpeeIRwopoApWL8lM5H82uwvkRkUmyrpMFNYwlSghs5TGubr2Q9Bx91hL39Opif9b72BWR3jYErXY2vTEsyCqMbTiUogGhOyEweKWwqcCzfmns1FwpXytPQhVpeCJRAVsVioQPg8lpqxF6SRZql-hQ3mTNgSm3klWtUg5vAF-K4zANXEtTbI590_HMmK4xyP2lhEEOsgHKLTMIwmJRwMQOpOeFlSe_xdrItQ2YsgH3dxIVtdRtX2joLY1p7QibYD5UhpB4n2bK2YI5UTOLEyyDsEWlQ2t-61ShRyP_AgqnMDg3wqJFCvwE-WomqPgIUjMGqSRzVJ0AeyPr0Dc1TpozzCOBkiR9tiBnm_n8Y7scYu1dmmkPFthmxLBnlZYn-_aAaBMTh3jkG82q6oPZX6TDqfFWzlEJHjmUIG-bjfP3ceN2zSqNqkr_9R7g15YGN5UZENOyKN9Wqj34J_uI5b5LBzMYDR71kt0uz2R-OzVpFrgXHo-K1KYfwBM2htjg |
| linkProvider | Unpaywall |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF5VRaJcEG8MhS4SFRKSSbzr5wEhN7RK2qRCpJV62653100g2CFOqPIv-CX8RmYcO9QUcevFB-_4tTP-5rE7M4S8VtIzoFe0LbnLbdfzQlsmaWC7iWknniONMRjvGBz73VP38Mw72yC_6lwY3FZZY2IJ1DpXGCNvoaUPti9z-Ifpdxu7RuHqat1CYyUWR2Z5CS5b8b73Efi7y9jB_kmna1ddBWzlBXxuO5I7YGQHJtUpOAdStZNI-44GXeclfsB8mfpaB0aF4DoqyVMw0nkidSRDP1EGA6AA-bdczgIEgrDjrGM6bQ7OA66GYhogNgBqHcbxuyFnYFb5DcVX9ge4rgWuqMG_t2huLbKpXF7KyeSK_ju4R-5WhiuNV5J2n2yY7AG5PaiW5h-Sn8N8OgJ5oulE_ihrRBU0nnyVk3ysCyozTTs5XotJJTM4R4dLTDss60TD45Y0XlxgpJL2-gDaLTh69DOKDcVQMQUtOeU2Fsm296dYQRSTL-kg17jVqZQuOs5oXMxH3yT9tDfoFI_I6Y0w5jHZzPLMPMVEdC6ZwqRfhdo3Sny4Aa6JRgBhvjEWeVvzQqiqFjq25JgI8ImQcQIYJyrGWSDRNfF0VQLk32R7yNQ1CdbtLk_kswtRwYCIEmYCaVLDIu0qxaLUBMxo7irtRm6iLbKDIiFWSbBr9BGxH0YBeH9eZJE3JQXiD7yyklUaBXw4VvJqUG43KAE3VHO4FjtR4VYh_vxlFnm1HsYrcS9eZvJFSRMyjlWZLPJkJaXrj-bgQIMR6FokaMhvY1aaI9l4VFY1B88dew9ZZHct6dem-4uUolhN97P_v_4O2eqeDPqi3zs-ek7uMNyJVAbOtsnmfLYwL8CUnCcvy_-XkvObBozfEq6IQw |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF5VRSpcEG8MhS4SFRKSSbzr5wEhN23UtE1VESr1Zta76zZgbBMnVPkX_B5-HTOObWqKuPWSgz127J3xN4-dByGvpXA06BVlCm5z03Yc3xRx4pl2rPuxYwmtNcY7xsfu_ql9cOacrZFfTS0MplU2mFgBtcolxsh7aOmD7css3kvqtIiT3eGH4ruJE6Rwp7UZp7ESkUO9vAT3rXw_2gVebzM23Ps02DfrCQOmdDw-Ny3BLTC4PZ2oBBwFIftxoFxLgd5zYtdjrkhcpTwtfXAjpeAJGOw8FioQvhtLjcFQgP9bHndd7NvvD6w2vtPn4EjgziiWBOIwoN5BGL6bcAYmlttRgtWsgOsa4YpK_Dtd8_YiK8TyUqTpFV04vEfu1kYsDVdSd5-s6ewB2RjX2_QPyc9JXlyAbNEkFT-qflElDdOvIs2nqqQiU3SQ47VYYDKDY3SyxBLEqmc0_N2ShotzjFrS0REAeA9-HfoRRYhi2JiCxiy4iQ2zzb0Cu4liISYd5wrTnipJo9OMhuX84pugJzvjQfmInN4IYx6T9SzP9FMsSueCSSwAlqiJg9iFG-D-aABw5mptkLcNLyJZ90XH8RxpBP4RMi4CxkU14wyQ7oa4WLUD-TfZDjK1JcEe3tWBfHYe1ZAQBTHTntCJZoGypWRBoj2mFbelsgM7VgbZQpGIVgWxLRJFoesHHniCTmCQNxUFYhE8shR1SQW8OHb16lBudigBQ2T3dCN2UY1hZfTnizPIq_Y0Xol5eZnOFxWNzzh2aDLIk5WUti_NwZkGg9A2iNeR386qdM9k04uqwzl48TiHyCDbraRfW-4vQkTlarmf_f_xt8gGQEV0NDo-fE7uMExKqmJom2R9PlvoF2BVzuOX1edLyeebxovfePWMfQ |
| linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9NAEF6VVAIuvB-GAosEQkJymnjttX10o1alIlVFqFROq325CTV2FDtF4Vfwk5mxnahuOcDFirxjy-t8Oy_PfEvIOy0DC3bFuJL5zPWDIHKlSkPXV3aggqG01mK-Y3zMD0_9o7PgbIt4614YLKs0xWVTBdpkk2yFFEU1WQT-AAUWhgOf3SLbPAD_u0e2T49Pkm_NLiqRy2MeNI14uAXP7ncp-yXzwLHhHdNTM_Tf1MNXDNH1Isk7y3wuVz9lll2xQAf3m67AsiYuxMKTi_6yUn396xqt4_9N7gG51zqkNGkQ9JBs2fwRuT1uP7k_Jr8nxXwKOKFpJi9r7qeSJtmFzIqZKanMDR0VeC02iyzgHJ2ssJ2w5n-GSaxosjzHDCT99BmU8S4cA_oF4UAxBUzB-s2Zi-TX7v4cmUGxqZKOC4MlTDVq6CynSVlNf0h6sjcelU_I6cH-19Gh227j4OogZJU7lGwIUU1oU5NCNCb1QMWGDw04F4Hiocdlyo0JrY4gVteSpRAVMSVNLCOutGXsKenlRW6fY4M5k57GZl6NVjVWHG6A3zpjUE3cWod8XP_DQrcc57jVRiYg1kE4iKMkEZMGDg4gdS08b6g9_i62h1DZiCAfd32iWJyLdnmLWHk2lDa1Xmx8rb04taFnDfO18WNfGYe8QaCJprl1o1VEwqM4hKguiB3yoZZAvQKPrGXbHgETR2B0JHc6kqAPdHd4DWbR6qNSYJwMkaM3ZA55uxnGK7HGLrfFspaJPIZsSw551mB_M2kGgTE4d75Dws6q6LyV7kg-m9Zs5RCR455CDnm_WT83XjcsUtEu0hf_KPeS3PWwvKjOhu2QXrVY2lfgH1bqdasQ_gDipWhm |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Sophora+flavescens+Alkaloids+and+Corticosteroid+Synergistically+Augment+IL-10%2FIL-5+Ratio+with+Foxp3-Gene-Epigenetic+Modification+in+Asthma+PBMCs&rft.jtitle=Journal+of+asthma+and+allergy&rft.au=Song%2C+Ying&rft.au=Wang%2C+Zhen-Zhen&rft.au=Wang%2C+Lixin&rft.au=Faybusovich%2C+Paul&rft.date=2021-01-01&rft.issn=1178-6965&rft.eissn=1178-6965&rft.volume=14&rft.spage=1559&rft_id=info:doi/10.2147%2FJAA.S321616&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1178-6965&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1178-6965&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1178-6965&client=summon |